MUC4 and familial pancreatic carcinoma: The present study suggests anti-MUC4-IR800 labeling can be used to better identify liver metastasis and peritoneal metastatic pancreatic cancers from surrounding normal tissues and improve operative staging for patients with pancreatic cancer.